How Long for EF to Improve After Bypass Surgery?

Ejection fraction after coronary artery bypass grafting typically starts improving within the first few weeks, with the most meaningful gains appearing between three and six months after surgery. The recovery curve is not a single jump but a gradual climb, and how far it climbs depends heavily on how much of the heart muscle was scarred versus merely “sleeping” before the operation. Patients with severely reduced EF before bypass tend to see the most dramatic early bounce, though maintaining that gain over years is a separate challenge.

The First Weeks After Surgery

Even within the first month, measurable improvement can appear. In a study of patients whose preoperative EF ranged from 18% to 27%, the average EF rose to about 31% within 30 days of surgery.¹ That early bump matters psychologically as much as medically: it reassures patients that the surgery did something, even though the heart is still recovering from the trauma of the operation itself.

Research tracking heart-wall movement after revascularization found that segments of muscle with reversible dysfunction recovered in a gradual, predictable pattern. The median time constant for that recovery was about 23 days, though it ranged from as little as 6 days to as long as 78 days depending on the person.² In practical terms, some segments of the heart start contracting better within a couple of weeks, while others take two or three months to wake up.

The Three-to-Six-Month Peak

The strongest gains in EF tend to arrive in the three-to-six-month window. A study that tracked patients at multiple intervals after revascularization found that EF assessed before three months averaged about 42%, but by three to six months it climbed to roughly 46% and stayed in that range through 12 months.³ The difference between the early post-op reading and the three-to-six-month reading was statistically significant, while later readings at six-to-nine and nine-to-twelve months were essentially flat compared to the three-to-six-month mark. This suggests the heart reaches a plateau around the half-year point for most patients.

A separate study of patients with ischemic cardiomyopathy confirmed continuous recovery throughout the first year. At three months, the median EF increase was about 15 percentage points, and by one year it had grown to about 23 points. Roughly three-quarters of patients achieved at least a 10-point absolute increase by three months, and close to 80% reached that threshold by one year.⁴ The takeaway is that EF keeps creeping upward between three and twelve months, though the pace slows considerably after six months.

For patients whose preoperative EF was severely depressed, a study measuring function at a mean of about 13 months post-CABG found that EF rose from a median of 28% to 39%.⁵ That 11-point jump is substantial. For many of these patients, it means moving from a range associated with severe heart failure into one where the heart pumps well enough to support a more active daily life.

What Happens Over Years, Not Months

The longer view is more complicated. A study following patients over a median of about 10.5 years found an important split: patients who started with the lowest preoperative EF showed the biggest initial improvement but then experienced a steady decline over the years. Meanwhile, patients who went into surgery with a somewhat higher EF had a smaller initial bounce but held onto their gains for longer.⁶ This pattern makes intuitive sense. A heart that was barely pumping before surgery has more room to improve, but it may also have more underlying disease driving it back down over time. A heart that entered surgery at, say, 30% to 35% gets a modest boost but tends to stay in that improved range for years.

This is worth keeping in mind at follow-up appointments. An EF that looks great at six months may not stay that way at five or ten years, especially if the patient had extremely low function to begin with. Ongoing medical therapy, risk factor management, and lifestyle changes all factor into whether those early gains stick.

Why Some Hearts Respond More Than Others

The single biggest predictor of EF improvement is how much of the heart muscle is alive but underperforming versus how much is permanently scarred. Muscle that has been starved of blood flow for a long time can enter a state sometimes called hibernation: it stops contracting normally but it is not dead. Restore the blood supply, and it can wake up. Scar tissue, by contrast, is not coming back regardless of how good the bypass grafts are.

Cardiac MRI can map this distinction. One study found that the number of segments with full-thickness scar and the size of the left ventricle at end-systole were independent predictors of whether EF would fail to improve after CABG.⁷ More scar means less recoverable muscle, and a larger, more dilated ventricle at baseline suggests more advanced remodeling that is harder to reverse.

Another study combined MRI with metabolic imaging and confirmed that the presence of hibernating myocardium was a driver of EF improvement after bypass. Patients whose scar segments made up a larger share of their heart wall were less likely to see their pump function bounce back.⁸ Where the viable muscle sits also matters. Research has specifically identified that higher viability in the anterior wall of the heart predicts a better functional result. Patients who improved tended to have lower preoperative EF and more living tissue in the front of the heart.⁹

An older study using positron emission tomography and stress echocardiography to detect viability found that only about 47% of patients showed meaningful functional improvement (defined as at least a 5-point EF increase) when reassessed roughly 10 weeks after surgery.¹⁰ That figure is a useful reality check. Even with successful revascularization, roughly half of patients with severe dysfunction may not see a clear EF bounce early on, largely because scar has already replaced too much of the working muscle.

Does Surgical Technique Affect Recovery?

How thoroughly the surgeon restores blood flow makes a measurable difference. A study comparing complete revascularization (bypassing all significantly blocked arteries) to incomplete revascularization found that the complete group gained an average of about 11 percentage points of EF at one year, compared to about 8 points in the incomplete group. The complete group also had a substantially lower risk of death over follow-up.¹¹

The choice of graft material is more contested. An older study found that patients who received vein grafts showed better early LV function recovery than those who received all-arterial grafts, and multivariate analysis identified graft type and preoperative EF as independent predictors of postoperative myocardial outcome, with vein grafts having a positive impact.¹² However, a more recent study found the opposite: total arterial revascularization produced a significantly higher increase in EF and better measures of heart-wall strain at both 6 and 12 months, along with higher graft patency rates at one year.¹³ The discrepancy likely reflects improvements in arterial grafting techniques and patient selection over the intervening decades. Modern arterial grafts, when they remain open, deliver excellent long-term flow.

As for whether the operation is done on-pump (using a heart-lung machine) or off-pump (on the beating heart), at least one study found no significant difference in right ventricular function between the two approaches at the end of surgery.¹⁴ The choice between these two methods is driven by many clinical factors, but the expected EF trajectory does not appear to be dramatically different between them.

Cardiac Rehabilitation Makes a Real Difference

What you do after surgery can be as important as what happens in the operating room. A randomized trial comparing exercise-based cardiac rehabilitation to usual care after coronary artery disease treatment found a striking gap: the exercise group saw their EF climb from about 47% to roughly 62%, while the control group’s EF barely budged.¹⁵ That is a dramatic difference. It also showed that the type of exercise program (hospital-based versus community-based) did not matter much; what mattered was doing structured exercise at all.

Another study confirmed that cardiac rehabilitation after CABG led to significant improvements in exercise capacity, blood pressure responses, heart rate, and ejection fraction, compared to a reference group that did not participate in a structured program.¹⁶ The message here is clear: bypass surgery opens the arteries, but regular exercise helps the heart muscle make the most of the restored blood flow. Patients who skip rehab leave potential EF recovery on the table.

CABG Versus Medical Therapy Alone in Low-EF Patients

The landmark STICH trial enrolled over 1,200 patients with an EF of 35% or less and randomly assigned them to either medical therapy alone or medical therapy plus bypass surgery. The initial results showed a trend toward lower death rates in the surgery group, but the difference did not quite reach conventional statistical significance for the primary outcome of all-cause death. However, the combined outcome of death or hospitalization for cardiovascular causes was significantly lower in the CABG group, with about 58% experiencing that endpoint versus 68% in the medical-therapy group.¹⁷

The 10-year follow-up of that same trial showed clearer separation. The CABG group experienced significantly fewer total hospitalizations over the long run.¹⁸ This trial is important context for EF recovery discussions because it established that bypass in low-EF patients is not just about pumping numbers on an echocardiogram. Even when EF improvement is modest, the surgery can reduce cardiovascular events and keep people out of the hospital.

When EF Does Not Improve

Not everyone sees their EF rise after bypass, and that naturally worries patients. But one of the more reassuring findings in this area comes from a study that compared outcomes in patients whose EF improved after CABG to those whose EF stayed flat. Survival free of cardiac death was essentially the same in both groups: about 93% to 94% over a mean follow-up of roughly 32 months.¹⁹ The researchers concluded that successful revascularization, even without a visible EF improvement, likely protects against future heart attacks and death by restoring blood flow to vulnerable muscle.

This finding does not mean EF is irrelevant. A higher EF generally predicts better exercise tolerance, fewer heart failure symptoms, and a lower risk of dangerous heart rhythms. But it does mean that if your EF has not budged three to six months after surgery, the operation was not wasted. The restored blood flow is still doing protective work beneath the surface, in ways that do not necessarily show up on a standard echocardiogram.

Tracking Recovery With Biomarkers

Echocardiography is the standard way to measure EF over time, but some clinicians also track blood markers to get a sense of how the heart is remodeling. A review of imaging and biomarker evidence found that a decline in NT-proBNP levels (a protein released by stretched heart muscle) during follow-up was associated with better structural and clinical outcomes.²⁰ If your cardiologist orders NT-proBNP tests after surgery, a downward trend is a good sign that the heart’s workload is easing. Other markers like troponins are less clearly useful for tracking recovery, as opposed to detecting acute damage.

The Right Ventricle Tells a Different Story

Most conversations about EF after bypass focus on the left ventricle, which does the heavy lifting of pumping blood to the body. But the right ventricle, which pushes blood through the lungs, often takes a hit during the surgery itself and can stay depressed for a surprisingly long time. One study found that right ventricular function, measured by how far the tricuspid valve ring moved, dropped by nearly half from its preoperative value and remained reduced a full year after CABG. Paradoxical motion of the wall between the two ventricles was present in 97% of patients at one year.²¹

This finding can alarm patients who see it on their echo reports, but the clinical significance appears limited for most people. The right ventricle adapts, and the abnormal septal motion is thought to be a compensatory mechanism rather than a sign of damage. Still, it is worth knowing that a report mentioning reduced right-sided function after bypass is not unusual and does not necessarily indicate a problem with the grafts or the overall success of the surgery. It is one of those quirks of post-surgical cardiac anatomy that persists even when the left ventricle is recovering nicely.